Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Santarus, Inc. (SNTS) to Present at the ROTH Capital Partners 24th Annual Conference

Santarus is a specialty biopharmaceutical company dedicated to acquiring, developing, and commercializing proprietary products for addressing the needs of patients being treated by physician specialists. The company is currently focusing its commercial efforts on Glumetza and Cycloset tablets, indicated as adjuncts to diet and exercise for improving glycemic control in adults with type 2 diabetes, and Fenoglide tablets, indicated as adjunct to diet for reducing high cholesterol. For more information, visit the company’s Web site at www.santarus.com

ROTH Capital Partners is a relationship-driven investment bank that primarily focuses on connecting small-cap publicly traded companies with institutional investors. This year’s annual ROTH conference will take place at The Ritz Carlton located in Dana Point, CA, on March 11-14. Bringing together executives from more than 400 growth companies, the 24th Annual ROTH Conference is one of the largest of its kind in the U.S. For more information on ROTH Capital Partners, visit www.roth.com

Let us hear your thoughts below:

This year's annual ROTH Conference will take place at The Ritz Carlton located in Laguna Niguel, on March 17-12, 2013. Bringing together executives from more than 400 growth companies, the ROTH Conference is one of the largest of its kind in the U.S. For more information on ROTH Capital Partners, visit www.roth.com.
This entry was posted in ROTH Capital Partners Conference. Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *